P650: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-5948, AN ORAL BTK DEGRADER, IN PATIENTS WITH RELAPSED AND REFRACTORY B-CELL MALIGNANCIES 由 K. Linton, G. P. Collins, D. El-Sharkawi, R. Mous, F. Forconi, M. Tan, S. Nandakumar, E. Meredith, K. L. Jameson, S. G. Injac, J. Doorduijn

获取全文

S208: EFFICACY AND SAFETY OF ZANDELISIB ADMINISTERED BY INTERMITTENT DOSING (ID) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA: PRIMARY ANALYSIS OF THE GLOBAL P... 由 A. Zelenetz, W. Jurczak, V. Ribrag, K. Linton, G. Collins, J. Lopéz-Jiménez, N. Reddy, A. Mengarelli, T. Phillips, G. Musuraca, O. Sheehy, J. Li, W. Xu, M. Azoulay, R. Ghalie, P. L. Zinzani

获取全文

P1141: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: A MULTICENTRE, REAL-WORLD UK STUDY 由 A. Tivey, R. Shotton, T. A. Eyre, D. Lewis, N. Crosbie, E. Nga, R. Guerrero Camacho, W. Swe, H. Marr, C. Rees, S. Moule, T. Sutton, D. Wrench, N. Thomas, M. Wilson, J. Bailey, M. Prahladan, A. Hodson, M. Koppana, S. Smith, S. Jones, F. Miall, J. Norman, E. Davies, C. Hildyard, L. Lowry, S. Paneesha, I. Qureshi, A. Beech, C. Bedford, A. Everden, D. Tucker, J. Wright, J. Goddard, T. Nicholson, J. Wilson, A. Lord, B. Jackson, M. Flont, A. Gibb, K. Linton

获取全文